Eton Pharmaceuticals, Inc. (ETON) vs Inhibrx Biosciences Inc. (INBX)
A side-by-side comparison of Eton Pharmaceuticals, Inc. and Inhibrx Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETON
Eton Pharmaceuticals, Inc.
$55.09HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
INBX
Inhibrx Biosciences Inc.
$95.99HealthcareDelayed quote: Oct 6, 2026, 11:04 AM EDT
Total return — ETON vs INBX
growth of $100 · dividends reinvested · last 6yETON +654.7% (+40.1%/yr)INBX +382.3% (+30.0%/yr)ETON compounded faster over this window
ETON INBX
ETON vs INBX: by the numbers
- •ETON is the larger company ($1.51B vs $1.41B market cap).
- •ETON is profitable (12.02% net margin) while INBX runs a net loss (-10773.46%).
Metrics side by side
Valuation
| Metric | ETON | INBX |
|---|---|---|
| P/E ratio | 143.23 | N/A |
| Forward P/E | 50.65 | N/A |
| P/S ratio | 14.29 | N/A |
| P/B ratio | 32.39 | N/A |
| EV / EBITDA | 72.47 | N/A |
| FCF yield | 0.98% | N/A |
Profitability
| Metric | ETON | INBX |
|---|---|---|
| Gross margin | 57.87% | -91.00% |
| Operating margin | 0.09% | -10386.54% |
| Net margin | 12.02% | -10773.46% |
| ROE | 27.24% | N/A |
| ROIC | 20.41% | -99.35% |
Growth (annualized)
| Metric | ETON | INBX |
|---|---|---|
| Revenue CAGR (5Y) | 47.98% | N/A |
| Total return CAGR (5Y) | 63.04% | 27.64% |
Frequently asked
- Is ETON or INBX more profitable?
- ETON runs the higher net margin — ETON at 12.02% versus INBX at -10773.46%.
- How have ETON and INBX total returns compared?
- Over the past 5 years, ETON delivered 63.04% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eton Pharmaceuticals P/E ratioEton Pharmaceuticals ROEInhibrx Biosciences ROEEton Pharmaceuticals operating marginInhibrx Biosciences operating marginEton Pharmaceuticals revenue growthInhibrx Biosciences revenue growthEton Pharmaceuticals free cash flowInhibrx Biosciences free cash flow
Eton Pharmaceuticals & Inhibrx Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.